Open Access

ARTICLE

Bendamustine and rituximab as frontline therapy in extranodal marginal zone lymphoma: a single-institution experience

CONSTANTINE N. LOGOTHETIS¹, NATHAN P. HORVAT², TONY KURIAN³, CELESTE BELLO³, JULIO CHAVEZ³, LEIDY ISENALUMHE³, BIJAL SHAH³, LUBOMIR SOKOL³, HAYDER SAEED³, JAVIER PINILLA³, SAMEH GABALLA^3,*

1 Department of Internal Medicine, University of South Florida, Tampa, FL, 33602, USA
2 College of Medicine, University of South Florida Morsani, Tampa, FL, 33602, USA
3 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA

* Corresponding Author: SAMEH GABALLA. Email: